We are seeking a full-time Postdoctoral Researcher in Radiopharmaceutical Formulation and Delivery to join the CRUK/MRC Oxford Institute for Radiation Oncology, Oxford.
You will be joining an established team working on an Engineering and Physical Research Council (EPSRC) funded project, investigating the use of ultrasound to enhance the delivery of drugs and genes. You will be appointed within the CRUK/MRC Oxford Institute for Radiation Oncology and will interface very closely with other scientists appointed to this EPSRC programme, based in the CRUK/MRC Oxford Institute for Radiation Oncology, and the Departments of Engineering (Institute of Biomedical Engineering, IBME) and Clinical Medicine.
You will hold (or be working towards) a PhD in biotechnology, biophysics, cell biology or pharmaceutical sciences, with a strong interest in cancer biology, radiobiology and therapeutics. Experience of working with radiopharmaceuticals and formulation of drug delivery systems is also an essential requirement of the role. In addition, you will need to have (or obtain) a Home Office Personal Licence and will have experience of undertaking experiments in mouse models including tumour growth, treatment and survival studies. Familiarity with the principle of pharmacokinetics and drug delivery will be advantageous, as will familiarity with cancer biology and vascular structure.
This is a full-time post and is offered for 1 year in the first instance with the possibility to extend to 2 years.
All applicants must complete a short application form and upload a CV and supporting statement. To apply for this role, please click on the ‘Apply Now’ button in the link below.
The closing date for applications is 12.00 noon on Monday 12 June 2017.